Infection Control News

“Network immunity” may have helped halt the global mpox outbreak, according to a study presented at the European Congress of Clinical Microbiology & Infectious Diseases.

Personal protective equipment and other supplies made using 3D printers may be “readily contaminated” with nosocomial pathogens and are best for one-time use, researchers reported.

Sleep disturbance was common among patients hospitalized for COVID-19 and was associated with symptoms of long COVID, including breathlessness and reduced lung function, a study found.

HHS announced a $1.1 billion program to keep COVID-19 vaccines and treatments free for uninsured people once the public health and national emergencies end next month in the United States.

Mutations have allowed SARS-CoV-2 to evade previously effective treatments and preventives that have become a crucial tool for reducing severe COVID-19 and have made treating outpatients with COVID-19 more complicated.

Bivalent messenger RNA booster vaccinations were effective for preventing COVID-19 hospitalizations and deaths in older adults, according to data presented at the European Congress of Clinical Microbiology & Infectious Diseases.

The FDA’s Antimicrobial Drugs Advisory Committee voted unanimously in favor of approving sulbactam-durlobactam for adults with hospital-acquired and ventilator-associated bacterial pneumonia, Innoviva announced Monday.

The FDA on Tuesday authorized a second bivalent COVID-19 vaccine booster shot for adults aged 65 years or older and most immunocompromised patients, among other changes the agency said will simplify the U.S. vaccine schedule.

It has been more than 40 years since HIV emerged, causing a pandemic that has left more than 40 million people dead and more than 38 million currently living with the infection worldwide.

The number of reported cases of chlamydia, gonorrhea and syphilis in the United States increased between 2020 and 2021, CDC data show.